Drug Database
Back to search

Czechia· CZ-0272242

RYZNEUTA

A efbemalenograstim alfa product containing efbemalenograstim alfa, registered in Czechia by FISIOPHARMA S.R.L., NUCLEO INDUSTRIALE, PALOMONTE. The same ATC class is registered in 9 of our 19 countries.

ATC L03AA18

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedRYZNEUTAATCL03AA18REGISTER NO.CZ-0272242PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about efbemalenograstim alfaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Efbemalenograstim alfa is registered in 9 of 19 countries.

Countries holding a registration under ATC L03AA18 (efbemalenograstim alfa), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose
Search efbemalenograstim alfa products by name

Efbemalenograstim alfa · ATC L03AA18

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
EFBEMALENOGRASTIM ALFA
Manufacturer
FISIOPHARMA S.R.L., NUCLEO INDUSTRIALE, PALOMONTE
Country
Czechia (CZ)
ATC code
L03AA18
ATC class
Efbemalenograstim alfa
Defined daily dose
20 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Efbemalenograstim alfa in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All efbemalenograstim alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ryzneuta
  • Liechtenstein · Ryzneuta
  • Norway · Ryzneuta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ca606ae-6d8e-43c9-90c2-bc2a4265c619
GET /v1/drugs/0ca606ae-6d8e-43c9-90c2-bc2a4265c619?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL ISP",
  "source": "sukl",
  "strength": "20MG",
  "pack_size": "1X1ML",
  "substance": "EFBEMALENOGRASTIM ALFA",
  "cz_kod_sukl": "0272242",
  "product_type": "BT",
  "substance_codes": "22277",
  "registration_state": "R",
  "registration_number": "EU/1/24/1793/001"
}
API referenceMCP serverPlans

See everything about efbemalenograstim alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console